We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$5.02B
AUM Growth
+$1.17B
Cap. Flow
+$816M
Cap. Flow %
16.26%
Top 10 Hldgs %
31.54%
Holding
2,471
New
743
Increased
409
Reduced
522
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 10.94%
2 Financials 10.6%
3 Healthcare 8.31%
4 Industrials 7.75%
5 Consumer Discretionary 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUV icon
2026
Southwest Airlines
LUV
$19.8B
-104,418
Closed -$3.57M
LX
2027
LexinFintech Holdings
LX
$219M
-77,600
Closed -$826K
LXFR icon
2028
Luxfer Holdings
LXFR
$460M
-10,600
Closed -$150K
LXRX icon
2029
Lexicon Pharmaceuticals
LXRX
$1.02B
-25,622
Closed -$51K
LYRA
2030
DELISTED
LYRA THERAPEUTICS INC
LYRA
-1,670
Closed -$947K
MA icon
2031
Mastercard
MA
$509B
-6,790
Closed -$2.01M
MATW icon
2032
Matthews International
MATW
$664M
-23,634
Closed -$451K
MATX icon
2033
Matsons
MATX
$6.66B
-16,203
Closed -$472K
MBWM icon
2034
Mercantile Bank Corp
MBWM
$1.03B
-8,864
Closed -$200K
MCFT icon
2035
MasterCraft Boat Holdings
MCFT
$617M
-12,910
Closed -$246K
MCHI icon
2036
iShares MSCI China ETF
MCHI
$6.3B
-57,247
Closed -$3.75M
MCRI icon
2037
Monarch Casino & Resort
MCRI
$2.26B
-19,549
Closed -$666K
MDLZ icon
2038
Mondelez International
MDLZ
$82.3B
-55,652
Closed -$2.85M
MEI icon
2039
Methode Electronics
MEI
$507M
-30,467
Closed -$952K
LITS
2040
Lite Strategy Inc
LITS
$33.7M
-1,060
Closed -$88K
MELI icon
2041
Mercado Libre
MELI
$97.5B
-380
Closed -$375K
MGNX icon
2042
MacroGenics
MGNX
$261M
-27,414
Closed -$765K
MGV icon
2043
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
-9,600
Closed -$703K
MIRM icon
2044
Mirum Pharmaceuticals
MIRM
$5.87B
-17,600
Closed -$342K
MITT
2045
TPG Mortgage Investment Trust
MITT
$213M
-3,473
Closed -$33K
MKC icon
2046
McCormick & Company Non-Voting
MKC
$14.9B
-6,606
Closed -$593K
MLAB icon
2047
Mesa Laboratories
MLAB
$698M
-5,014
Closed -$1.09M
MMS icon
2048
Maximus
MMS
$3.05B
-25,259
Closed -$1.78M
MOD icon
2049
Modine Manufacturing
MOD
$10.5B
-24,789
Closed -$137K
MODV
2050
DELISTED
ModivCare
MODV
-4,392
Closed -$347K

Similar funds

Michael Gelband's Q3 2020 Portfolio in Review

As of Q3 2020, Michael Gelband held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael Gelband deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.

  • Michael Gelband's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
  • Michael Gelband added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
  • Michael Gelband's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
  • Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
  • Michael Gelband's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
  • Michael Gelband opened 743 new positions and closed 789 in Q3 2020.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $5.02B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.